SFPQ and Alzheimer disease: Four weeks postinjection, behavioral experiments were repeated, demonstrating that AD mice injected with AAV-SFPQ exhibited enhanced cognitive performance in the NOR and Y-maze tests compared to the control group, indicating that SFPQ overexpression improves cognition and memory in AD mice (Figure 1G,H).